CRM vs TSLA: Which Is the Better Buy?

Side-by-side comparison of Salesforce, Inc. and Tesla, Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-16.
Salesforce, Inc. ยท Technology
$181.22
+161.6% upside to fair value
High Conviction Grade A-
VS
Tesla, Inc. ยท Consumer Cyclical
$343.23
-5.3% upside to fair value
Low Conviction Grade D
QuantHub Verdict
CRM has more upside to fair value (+161.6%). CRM trades at a lower forward P/E (22.7x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric CRM TSLA
Current Price $181.22 $343.23
Fair Value Estimate $474.00 $325.00
Upside to Fair Value +161.6% -5.3%
Market Cap $169.8B $1,287.9B
Forward P/E 22.7x 205.5x
EV / EBITDA โ€” 108.8x
Price / Sales 4.1x 13.6x
Price / FCF 11.8x 207.1x
Revenue Growth YoY +9.2% -2.9%
Gross Margin 77.7% 18.0%
Operating Margin 21.5% 4.6%
Return on Equity 12.4% 4.8%
Dividend Yield โ€” 0%
FCF Yield 8.5% 0.48%
Analyst Consensus Strong Buy โ€”
Investment Thesis
CRM โ€” Salesforce, Inc.
Salesforce is the leading global provider of CRM software, offering a strong competitive moat through market dominance and high switching costs, complemented by acquisitions like Slack and Tableau, with excellent margins above 77% gross and robust free cash flow of $15.16 per share. Despite decelerating revenue growth at 9.2% YoY and negative earnings growth of -6.9%, the business remains high-quโ€ฆ
TSLA โ€” Tesla, Inc.
Tesla remains the most polarizing stock in markets. The core auto business is deteriorating: FY2025 revenue fell 2.9% to $94.8B, net income dropped 46.8% to $3.8B, and Q4 deliveries declined 15.6% YoY to 418K units. Yet the stock trades at 13.6x TTM P/S (near 5yr highs) on the optionality of Cybercab robotaxis launching April 2026, FSD reaching unsupervised status in Austin, and Optimus humanoid โ€ฆ
Accumulation Zones
Metric CRM TSLA
Zone Low $356.00 $244.00
Zone High $403.00 $276.00
In Buy Zone? Yes No
โ† CRM Research    TSLA Research โ†’    All Research